Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 98%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
41,743
Total Claims
$2.0M
Drug Cost
923
Beneficiaries
$2,207
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+13%
Opioid rate vs peers
2.5% vs 2.2% avg
+56%
Cost per patient vs peers
$2,207 vs $1,411 avg
-4%
Brand preference vs peers
10.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.5%
Opioid Rate
1,052
Opioid Claims
$21K
Opioid Cost
11.7%
Long-Acting Rate
Brand vs Generic
Brand: 4,265 claims · $1.3M
Generic: 37,354 claims · $718K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,157 | $337K |
| Rivaroxaban | 312 | $99K |
| Insulin Aspart | 149 | $51K |
| Mirabegron | 188 | $46K |
| Insulin Glargine,hum.Rec.Anlog | 134 | $32K |
| Empagliflozin | 108 | $32K |
| Memantine Hcl | 777 | $31K |
| Collagenase Clostridium Hist. | 66 | $26K |
| Potassium Chloride | 1,082 | $26K |
| Dapagliflozin Propanediol | 92 | $25K |
| Linagliptin | 84 | $25K |
| Dulaglutide | 30 | $24K |
| Linaclotide | 43 | $23K |
| Rifaximin | 14 | $23K |
| Divalproex Sodium | 516 | $22K |
Prescribing Profile
Patient Profile
79
Avg Age
64%
Female
2.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About